Sumavel DosePro

Sumavel DosePro is a brand name of sumatriptan, approved by the FDA in the following formulation(s):

SUMAVEL DOSEPRO (sumatriptan succinate - injectable; subcutaneous)

• 
  Manufacturer: ZOGENIX INC
  
  Approval date: July 15, 2009
  
  Strength(s): EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) ^[RLD]

Has a generic version of Sumavel DosePro been approved?

No. There is currently no therapeutically equivalent version of Sumavel DosePro available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sumavel DosePro. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Needle-less injector
  Patent 5,891,086
  Issued: April 6, 1999
  Inventor(s): Weston; Terence Edward
  Assignee(s): Weston Medical Limited
  In a needle-less injector combining an actuator and a medicament cartridge, the actuator includes a housing with a forward portion to which the cartridge is connected. An impact member is mounted within the housing inward of the forward portion so as to be movable toward the forward portion, where it may strike components of the cartridge to effect expulsion of a dose of medicament. A chamber is provided within the housing and is pre-filled with a pressurized gas which is in communication with and exerts a constant force on the impact member, tending to urge it towards the forward portion. Movement of the impact member is prevented by a latch which normally engages the impact member and prevents its forward movement, but is actuable to be moved out of such engagement, permitting movement of the impact member, the cartridge includes a piston which is mounted in the body of the cartridge with an interference fit and is made of a material which is substantially non-resilient when subjected to a slowly applied force, but is highly resilient when subjected to a rapidly applied force.
  
  Patent expiration dates:
  
  
  • July 27, 2014
    
    ✓ 
    Drug product
  
  



• 
  Spring-Powered dispensing device
  Patent 5,957,886
  Issued: September 28, 1999
  Inventor(s): Weston; Terence Edward
  Assignee(s): Weston Medical Limited
  A needleless injector is described for dispensing a liquid material, comprising a dispensing member which moves under the force of a spring providing an energy store. A damping arrangement, employing a viscous damping medium such as grease, is used to damp recoil during dispensing.
  
  Patent expiration dates:
  
  
  • March 8, 2016
    
    ✓ 
    Drug product
  
  



• 
  Spring-powered dispensing device for medical purposes
  Patent 6,135,979
  Issued: October 24, 2000
  Inventor(s): Weston; Terence Edward
  Assignee(s): Weston Medical Limited
  A dispensing device, such as a needleless injector, comprising a spring, which provides an energy store, and a dispensing member movable, to effect a dispensing, under the force of the spring. A latch has a first position in which it restrains movement of the dispensing member and a second position in which it permits such movement. A trigger is operable by the user for moving the latch from the first position to the second position. A safety mechanism, preferably in the form of an appropriately shaped slot in the dispensing member, is effective before the device has been completely assembled to prevent movement of the latch to the second position.
  
  Patent expiration dates:
  
  
  • March 21, 2017
    
    ✓ 
    Drug product
  
  



• 
  Device for readying a needle free injector for delivery
  Patent 7,776,007
  Issued: August 17, 2010
  Inventor(s): Schuster; Jeffrey A. & Bridges; Paul Stuart & Gibbins; Graham & Reid; Nicola
  Assignee(s): Zogenix, Inc.
  A needle-free injector device comprising a latch having a safe position which disables the triggering of the device, and a ready position which restrains movement of a dispensing member but enables triggering and a triggered position which permits movement of the dispensing member is disclosed. An additional safety mechanism blocks the triggering of the device until removed. A cap is provided to maintain the sterility and stability of the drug formulation and is configured such that the cap removal is required prior to placing the device in a ready to trigger state.
  
  Patent expiration dates:
  
  
  • November 28, 2026
    
    ✓ 
    Drug product
  
  



• 
  Casing
  Patent 7,901,385
  Issued: March 8, 2011
  Inventor(s): Anderson; Gregor John McLennan & Mitchell; John
  Assignee(s): Zogenix, Inc.
  A casing (50) for an injection device (10) of the type having a safety device which prevents operation of the device (10), incorporating an actuator means (56) by which the safety means of the device (10) can be actuated to allow operation of the device (10). Also a casing (50) for a medicament container having an opening closed prior to use by a break-off tip (135), having relatively moveable first and second casing parts (51, 52), which on relative movement apply a breaking force to the break-off tip (135). A preferred embodiment includes both such features.
  
  Patent expiration dates:
  
  
  • July 31, 2026
    
    ✓ 
    Drug product
  
  

See also...

• Sumavel DosePro Consumer Information (Drugs.com)
• Sumavel DosePro Consumer Information (Wolters Kluwer)
• Sumavel DosePro injection Consumer Information (Cerner Multum)
• Sumavel DosePro Advanced Consumer Information (Micromedex)
• Sumavel DosePro Subcutaneous Advanced Consumer Information (Micromedex)
• Sumatriptan Consumer Information (Wolters Kluwer)
• Sumatriptan Spray Consumer Information (Wolters Kluwer)
• Sumatriptan Tablets Consumer Information (Wolters Kluwer)
• Sumatriptan injection Consumer Information (Cerner Multum)
• Sumatriptan oral/nasal Consumer Information (Cerner Multum)
• Imitrex Stat Dose Refill Advanced Consumer Information (Micromedex)
• Imitrex Stat Dose Refill Subcutaneous Advanced Consumer Information (Micromedex)
• Sumatriptan Advanced Consumer Information (Micromedex)
• Sumatriptan Nasal, Oral, Subcutaneous Advanced Consumer Information (Micromedex)
• Sumatriptan Subcutaneous Advanced Consumer Information (Micromedex)
• Sumatriptan AHFS DI Monographs (ASHP)
• Sumatriptan Succinate AHFS DI Monographs (ASHP)